Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2010
11/25/2010US20100297209 Solvent/polymer solutions as suspension vehicles
11/25/2010US20100297179 Immunology Treatment for Biofilms
11/25/2010US20100297177 Mutated parvovirus structural proteins as vaccines
11/25/2010US20100297170 Vaccines
11/25/2010US20100297165 Immunostimulatory combinations of tlr ligands and methods of use
11/25/2010US20100297163 Recombinant malaria vaccine
11/25/2010US20100297157 Vaccine therapy for choroidal neovascularization
11/25/2010US20100297154 CD40 ligand-enhanced cells and methods of modulating an immune response to an antigen
11/25/2010US20100297153 Binding molecules for treatment and detection of cancer
11/25/2010US20100297150 Disease treatment via antimicrobial peptide inhibitors
11/25/2010US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
11/25/2010US20100297148 Cd38 modulated chemotaxis
11/25/2010US20100297147 Compositions and methods for modulating tlr14 activity
11/25/2010US20100297139 Methods and compositions for the treatment of proteinuric diseases
11/25/2010US20100297137 Hematopoietic Lineage Cell Specific Protein (HS1) as a Marker for Lymphoid Malignancy
11/25/2010US20100297136 Gastric and Prostate Cancer Associated Antigens
11/25/2010US20100297135 Epitope for neutralizing antibodies
11/25/2010US20100297131 Binding domain of plasmodium reticulocyte binding proteins
11/25/2010US20100297127 Use of il-27 antagonists to treat lupus
11/25/2010US20100297125 Methods of treating pain using antagonists of il-31, il-31ra and/or osmrb
11/25/2010US20100297124 Induced internalization of surface receptors
11/25/2010US20100297121 Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists
11/25/2010US20100297120 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
11/25/2010US20100297119 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/25/2010US20100297117 Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
11/25/2010US20100297109 Methods for inhibiting fascin
11/25/2010US20100297107 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
11/25/2010US20100297105 Administering antisense oligonucleotides complementary to human apolipoprotein b
11/25/2010US20100297104 Dendritic macromolecule and a process thereof
11/25/2010US20100297101 Integrin alpha. II .B.beta.3 Specific Antibodies and Peptides
11/25/2010US20100297100 Composition for Treating Retinopathy or Glaucoma Comprising Thrombin Derived Peptides
11/25/2010US20100297099 Airway Administration of Activated Protein C in Inflammatory Conditions Affecting the Respiratory Tract
11/25/2010US20100297098 Purification of Factor XIII Polypeptides from Biological Materials
11/25/2010US20100297097 Compounds
11/25/2010US20100297096 Amphiphilic peptide matrices for treatment of osteoporosis
11/25/2010US20100297095 Porifera-Based Therapeutic Compositions for Treating and Preventing Skin Diseases
11/25/2010US20100297082 Weight-bearing polyurethane composites and methods thereof
11/25/2010US20100297081 Pharmaceutical formulation containing recombinant human serum albumin-interferon alpha fusion protein
11/25/2010US20100297080 Genetic markers associated with interferon-alpha response
11/25/2010US20100297079 Compounds, compositions and methods for treating viral infection
11/25/2010US20100297078 Method for producing a hydroxyalkyl starch derivative with two linkers
11/25/2010US20100297077 Novel aryl potassium channel blockers and uses thereof
11/25/2010US20100297076 Targeted interferon demonstrates potent apoptotic and anti-tumor activities
11/25/2010US20100297075 Combinational compositions and methods for treatment of cancer
11/25/2010US20100297074 Wound healing compositions, systems, and methods
11/25/2010US20100297073 Heterocyclic antiviral compounds
11/25/2010US20100297072 Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy
11/25/2010US20100297071 Immune response inducer
11/25/2010US20100297070 COMPOSITIONS AND METHODS FOR AMELIORATING CNS INFLAMMATION, PSYCHOSIS, DELIRIUM, PTSD or PTSS
11/25/2010US20100297069 Pegylated interleukin-10
11/25/2010US20100297068 Methods for treating viral infection using il-28 and il-29
11/25/2010US20100297067 Methylation markers for prostate cancer and methods of use
11/25/2010US20100297066 Biodegradable peptide releasing polymers
11/25/2010US20100297065 Homogeneous preparations of il-31
11/25/2010US20100297064 Cytokine zalpha11 ligand antibodies
11/25/2010US20100297063 Cytokine zalpha11 ligand antibodies
11/25/2010US20100297062 Stable Formulations Of Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor
11/25/2010US20100297061 Stat3 antagonists and their uses as vaccines against cancer
11/25/2010US20100297060 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
11/25/2010US20100297054 1,2,3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
11/25/2010US20100297033 Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease
11/25/2010US20100297021 Variants of C-Type Natriuretic Peptide
11/25/2010US20100297020 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
11/25/2010US20100297017 Method for Synthesizing and Using Pegylated Peptide-Photoactive Chromophore Conjugates and Micellular Formulations Thereof
11/25/2010US20100297011 Isolated peptides and uses thereof
11/25/2010US20100297010 Tumor suppressor gene screening using rna interference libraries and method of treatment
11/25/2010US20100297006 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
11/25/2010US20100297005 Nucleic acids and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
11/25/2010US20100294716 Templated Native Silk Smectic Gels
11/25/2010US20100294677 High Concentration Factor VII Polypeptide Formulations Comprising an Aromatic Preservative and an Antioxidant
11/25/2010DE202010008608U1 Die pharmazeutische Zusammensetzung The pharmaceutical composition
11/25/2010CA2799711A1 Extended acting oxygen generating composition for treating microbial infections
11/25/2010CA2763283A1 Phytases, nucleic acids encoding them and methods for making and using them
11/25/2010CA2762989A1 Application and uses of prg4 and therapeutic modulation thereof
11/25/2010CA2762679A1 Compositions and methods to prevent cancer by stabilizing p53 through non mdm2-mediated pathways
11/25/2010CA2762652A1 Novel solid materials of {[(2s,5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them
11/25/2010CA2762625A1 Process for the preparation of ibodutant (men15596) and related intermediates
11/25/2010CA2762604A1 Bifunctional polypeptides
11/25/2010CA2762574A1 Combinations of immunostimulatory agents, oncolytic virus, and additional anticancer therapy
11/25/2010CA2762551A1 Cell-penetrating peptides
11/25/2010CA2762212A1 Elastin for soft tissue augmentation
11/25/2010CA2762179A1 Composition comprising oil drops
11/25/2010CA2762176A1 Marker differentially expressed in cancer stem cells and methods of using same
11/25/2010CA2761762A1 Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
11/25/2010CA2758581A1 Variants of c-type natriuretic peptide
11/25/2010CA2755948A1 Inhibition of prion protein propagation by receptor associated protein (rap), its derivatives, mimetics and synthetic peptides
11/24/2010EP2253957A1 Methods for producing an immune response to tuberculosis.
11/24/2010EP2253956A2 Immune response assessment method
11/24/2010EP2253703A1 Human coagulation factor VII variants
11/24/2010EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody
11/24/2010EP2253644A1 Compositions and methods for producing a composition
11/24/2010EP2253643A1 Novel compositions and methods in cancer associated with altered expression of PRLR
11/24/2010EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof
11/24/2010EP2253331A1 Modulation of antibody formation in mammals, applicability in gene therapy and animal model generation
11/24/2010EP2253327A1 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
11/24/2010EP2253326A1 Pharmaceutical composition for transnasal administration
11/24/2010EP2253324A1 Use of a casein-derived peptide and compositions thereof as antihypertensive
11/24/2010EP2253316A1 serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of vestibular deficits
11/24/2010EP2252630A2 Chimeric c3-like rho antagonist bone therapeutic
11/24/2010EP2252629A2 Use of defensins against tuberculosis
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 3163